Medirom Healthcare Technologies Inc.'s subsidiary, MEDIROM MOTHER Labs, entered a Capital and Business Alliance Agreement with Elematec Corporation on October 15, 2024, where Elematec will invest JPY 100,080,000 for 556 shares in MML and manage manufacturing of MML's devices. This agreement highlights a pre-money valuation of JPY 9 billion for MML based on its 50,000 outstanding shares as of August 31, 2024.